Concepedia

Jasna Hocevar‐Trnka

JH

Statistics

Publications

2

Citations

49

H-Index

2

Active since

2020

Affiliations

Impel Neuropharma (United States)(Current)

Jasna Hocevar‐Trnka is an author at Impel Neuropharma (United States).

Publications per year

2020–2021

2

Publications

2

STOP 301: A Phase 3, open‐label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD <sup>®</sup> ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients

Timothy R. Smith, Paul Winner, Sheena K. Aurora et al. · Headache The Journal of Head and Face Pain · 2021 · 28 citations · Full text

The SNAP 101 Double-Blind, Placebo/Active-Controlled, Safety, Pharmacokinetic, and Pharmacodynamic Study of INP105 (Nasal Olanzapine) in Healthy Adults

Stephen B. Shrewsbury, Jasna Hocevar‐Trnka, Kelsey Satterly et al. · The Journal of Clinical Psychiatry · 2020 · 21 citations · Full text

1–2 of 2